News, Analysis & Insights on Nutrition, Supplements, and Health
One month after a Utah court issued a ruling on low dose ephedra products, the dietary supplements industry is still in limbo over the previously-banned herbal, since the FDA has not yet given any indication of its next course of action.
Irish firm Marigot has carried out a new trial demonstrating the benefits to bone health of its Calcilife ingredient, a combination product containing the mineral source Aquamin and NutriFlora short chain fructooligosaccharides (scFOS).
Ingredient marketer PL Thomas has signed an agreement with Israel's LycoRed to represent LycoMato to food, beverage and functional foods companies in the eastern US, Canada and Mexico.
A health claim for the prebiotic effect of inulin will be published by the French food safety authority tomorrow, giving food manufacturers in this market the go-ahead to promote the health benefits of inulin-containing foods, reports Dominique Patton.
Advitech's bid to exploit the potential of XP-828L in the anti-inflammatory market was given a boost this week when the Canadian government granted funding of C$610,000 towards its research project at Université Laval, reports Jess Halliday.
The UK's presidency of the European Union in July gives it a unique position to influence the outcome of Europe's food supplements directive, due to take effect in August but subject to a rewrite if a European court decision declares it invalid.
Diets rich in vitamin E could protect against the development of Parkinson's disease, suggests a new meta-analysis published today.
More than half of osteoporosis sufferers do not consume sufficient quantities of vitamin D, suggests new research - an oversight that could make them more vulnerable to falls and fractures.